At a glance
- Originator Meiji Seika Kaisha
- Developer Meiji Seika Pharma
- Class Antineoplastics; Contraceptives; Naphthols; Sesquiterpenes; Small molecules
- Mechanism of Action Progesterone receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Pregnancy
Most Recent Events
- 12 Feb 2015 Discontinued - Preclinical for Pregnancy (Prevention) in Japan (unspecified route) prior to February 2015
- 12 Apr 1999 New profile
- 12 Apr 1999 Preclinical development for Pregnancy (Prevention) in Japan (Unknown route)